abacavir 300 MG Oral Tablet

1 INDICATIONS AND USAGE Abacavir tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (HIV-1) infection. Abacavir, a nucleoside analogue human immunodeficiency virus (HIV-1) reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )

apotex corp

FDA Reported Adverse Reactions
`[1] fatigue` `[2] diarrhoea` `[3] off label use` `[4] nausea` `[5] drug ineffective` `[6] pneumonia` `[7] death` `[8] pyrexia` `[9] constipation` `[10] dyspnoea`

4 years ago

OVAL YELLOW APO AB 300

16 HOW SUPPLIED/STORAGE AND HANDLING Abacavir Tablets, USP containing abacavir sulfate equivalent to 300 mg abacavir are yellow, biconvex, scored, capsule-shaped, film-coated tablets engraved with “APO” on one side and “AB” bisect “300” on the other side. They are packaged as follows: Bottles of 60 tablets (NDC 60505-3583-6). Unit Dose packs of 60 tablets (NDC 60505-3583-0). Each pack contains 6 blister cards of 10 tablets each. Store at controlled room temperature 20°C to 25°C (68°F to 77°F) (See USP) Dispense in original container with attached prescribing information that contains the Medication Guide and a Warning Card.

More pills like OVAL APO AB 300

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

abacavir 300 MG Oral Tablet

FDA Reported Adverse Reactions [1] fatigue [2] diarrhoea [3] off label use [4] nausea [5] drug ineffective [6] pneumonia [7] death [8] pyrexia [9] constipation [10] dyspnoea

OVAL YELLOW APO AB 300

More pills like OVAL APO AB 300

FDA Reported Adverse Reactions
`[1] fatigue` `[2] diarrhoea` `[3] off label use` `[4] nausea` `[5] drug ineffective` `[6] pneumonia` `[7] death` `[8] pyrexia` `[9] constipation` `[10] dyspnoea`